Forest Labs’ Antidepressant Marketing Woes Continue


Forest Labs has been hit with a new lawsuit in Massachusetts, over misleading marketing of its antidepressant drugs Celexa and Lexapro to adolescents, even as it agreed to pay up to $10.4 million to settle accusations of misleading Missouri parents into buying the drugs for children though the drugs were only approved for adults.

Article →

Previous article“The Eradication of Schizophrenia in Western Lapland”: The Play
Next article“Research Confirms Antidepressant-Autism Link”
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].